Structured, dose-reduction and deprescribing, multi-diagnostic study in real-world settings

Structured, dose-reduction and deprescribing, multi-diagnostic study in real-world settings - SIMPLE

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036057

Enrollment

500

Registered

2025-02-06

Start date

2025-03-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deprescribing psychiatric medication

Interventions

Group 1: Affected persons with one or more mental illness(es) and relatives of persons with one or more mental illness(es) are surveyed with questionnaires on sociodemographics, diagnosis, previous an

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Presence of a mental illness or relationship to a person with a mental illness Experience with reducing or discontinuing psychiatric medication

Exclusion criteria

Exclusion criteria: Insufficient language skills

Design outcomes

Primary

Measure	Time frame
Attitudes towards deprescribing (rPATD)	—

Secondary

Measure	Time frame
Health literacy (HSL-EU-Q16) Stigma Substance use (part of WHO-ASSIST v3.0) Views on discrimination against people with mental illness (PDDQ) Attitudes towards psychiatric medication (DAI-10) Impact of climate change on mental well-being	—

Countries

Germany

Contacts

Public ContactTheresa Halms

Lehrstuhl für Psychiatrie und Psychotherapie der Universität Augsburg

theresa.halms@med.uni-augsburg.de+4982148031266

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026